Genetics & Genomics
Non-small cell lung cancer exhibits inactivation of PRSS3 putative tumor suppressor gene
Published in Gene Therapy Weekly, November 24th, 2005
"The serine protease family member PRSS3 (trypsinogen-IV has been implicated as a putative tumor suppressor gene due to its loss of expression, which is correlated with promoter hypermethylation, in esophageal squamous cell carcinoma and gastric adenocarcinoma. As epigenetic alteration is common in nonsmall cell lung cancer (NSCLC), we sought to determine if promoter hypermethylation of PRSS3 occurred in this disease, and if it was associated with clinical features of NSCLC or tobacco-related exposures in these patients," scientists in Massachusetts report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-11-24)
More Articles from Gene Therapy Weekly
- Immunotherapy
University of Manchester scientists receive grant to study T cell-mediated immunotherapy - Oncology
Small interfering RNA halts lymphangiogenesis and metastasis - Angiology
Gene transfer stimulates neoangiogenesis in rabbit peripheral ischemia models - Apoptosis
Full-length p73 alpha repressed drug-induced apoptosis in lung carcinoma cells - Awards
Biocompatible stent coatings company wins 2005 technology innovation award - DNA Research
Anticancer agent EZZ induces cell cycle arrest in S phase by inhibiting DNA replication - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
